# Gastrointestinal Safety Evaluation of Two Over the Counter Analgesics

> **NCT01822665** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 28 (actual)

## Conditions studied

- Gastrointestinal Mucosal Damage

## Interventions

- **DRUG:** Ibuprofen
- **DRUG:** Paracetamol
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01822665
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2014-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01822665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01822665, "Gastrointestinal Safety Evaluation of Two Over the Counter Analgesics". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01822665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*